Cognitive Function News and Research

RSS

Cognition is a concept used in different ways by different disciplines, but is generally accepted to mean the process of thought. For example, in psychology and cognitive science it refers to an information processing view of an individual's psychological functions.

Premenopausal use of hormonal contraceptives may improve women’s cognitive abilities

Premenopausal use of hormonal contraceptives may improve the cognitive abilities of women in midlife and for years afterward. This finding may have implications for prevention of declining cognitive function that occurs with advancing age and in diseases such as Alzheimer's.

8 Nov 2012

UC Santa Barbara reports key discovery in interdisciplinary study of split-brain research

UC Santa Barbara has reported an important discovery in the interdisciplinary study of split-brain research. The findings uncover dynamic changes in brain coordination patterns between left and right hemispheres.

3 Nov 2012

Advanced breast cancer that has spread to the brain could be treated with drug combination

The sizeable and increasing proportion of women with advanced breast cancer whose disease has spread to the brain could be effectively treated systemically with a combination of two drugs, sparing them the debilitating neurological side effects of whole brain radiotherapy (WBRT), suggests new research published Online First in The Lancet Oncology.

2 Nov 2012

Study identifies monoacylglycerol lipase as new therapeutic target to treat Alzheimer's

Research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, has identified an enzyme called Monoacylglycerol lipase (MAGL) as a new therapeutic target to treat or prevent Alzheimer's disease.

2 Nov 2012

Additional data from EnVivo’s EVP-6124 Phase 2b trial on AD presented at CTAD meeting

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today presented pharmacokinetic and pharmacodynamic data along with the previously reported statistically significant clinical results from its Phase 2b clinical trial of EVP-6124, a novel alpha-7 agonist, in patients with Alzheimer's disease.

1 Nov 2012

TTP488 slows cognitive decline in patients with mild to moderate Alzheimer's

A novel, orally administered drug candidate, TTP488, has demonstrated clinical evidence of slowing of cognitive decline over 18 months of therapy in patients with mild to moderate Alzheimer's disease.

30 Oct 2012

High-intensity training boosts cognitive function

A regular exercise routine can make you fitter than ever - mentally fit.

29 Oct 2012

High-intensity interval training makes middle-aged people smarter

High-intensity interval training makes middle-aged people not only healthier but smarter, showed a Montreal Heart Institute (MHI) study led by Dr. Anil Nigam of the MHI and University of Montreal, in collaboration with the Montreal Geriatric University Institute.

29 Oct 2012

ApoE4 gene becomes less important to quality of life once people hit their 90s

A gene linked to the risk of developing Alzheimer's, heart disease and diabetes becomes less important to quality of life once people hit their 90s, a Mayo Clinic study shows. At that point, good friends and a positive attitude have a bigger impact, the researchers say.

26 Oct 2012

BioLineRx intends to conduct interim analysis of BL-1020 Phase II/III trial for schizophrenia

BioLineRx, a biopharmaceutical development company, announced today that it intends to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.

25 Oct 2012

New data on Posiphen for Alzheimer's disease treatment to be presented at Biotech Symposium

QR Pharma, Inc., a clinical stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative disorders, announced today that Dr. Maria Maccecchini, CEO, will be presenting new data on its lead compound "Posiphen® Recovers Memory, Learning and Brain Function in Alzheimer Transgenic Mice" at the 12th Annual Biotech Symposium, taking place October 22, 2012 in Philadelphia, PA.

22 Oct 2012

Brain Injury Research Center of Mount Sinai receives fund to research on TBI

The Brain Injury Research Center of Mount Sinai has received two prestigious grants totaling $6.65 million to fund research on traumatic brain injury over the next five years.

20 Oct 2012

Novel insight into impact that Huntington's disease has on the brain

A study led by researchers at Boston University School of Medicine (BUSM) provides novel insight into the impact that Huntington's disease has on the brain.

19 Oct 2012

Blood pressure management may slow cognitive decline in PD

Cognitive dysfunction in Parkinson's disease is linked to neurocirculatory abnormalities such as orthostatic and supine hypertension, suggesting early treatment of such abnormalities may slow cognitive decline, say researchers.

17 Oct 2012

High-carb diet may increase risk of mild cognitive impairment among older people

People 70 and older who eat food high in carbohydrates have nearly four times the risk of developing mild cognitive impairment, and the danger also rises with a diet heavy in sugar, Mayo Clinic researchers have found.

17 Oct 2012

Brain’s biological mechanisms may contribute to diet-related disorders

Studies released today explore the neurological component of dietary disorders, uncovering evidence that the brain's biological mechanisms may contribute to significant public health challenges - obesity, diabetes, binge eating, and the allure of the high-calorie meal. The findings were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

17 Oct 2012

Adults with HIV can benefit from cognitive training exercises

As more effective antiretroviral therapy has evolved over the past 30 years, HIV/AIDS has shifted from an acute to a chronic condition. But as patients live longer, research indicates that they are experiencing cognitive impairments at a higher rate than people without the disease.

17 Oct 2012

Mephedrone and memory loss: an interview with Craig Motbey

Mephedrone is a fairly new designer drug which has been around for a few years. It exploded in popularity in Europe (and particularly in the UK) before it started to spread in a major way elsewhere.

16 Oct 2012

Cannabis and the endocannabinoid system: an interview with Dr Leonora Long

Cannabis has both physical and behavioural effects. People using cannabis can experience feelings of euphoria (well-being), hunger, sleepiness, problems with motor coordination, and sometimes feelings of anxiety and paranoia.

15 Oct 2012

Smoking cessation programs must be made available for current active-duty war fighters

In a new study published in Frontiers, Dr Timothy Durazzo and colleagues from the San Francisco VA Medical Center and University of California, San Francisco, expand upon their decade of research showing that smoking while kicking the alcohol habit impairs memory, learning and other cognitive skills--ultimately making it more difficult to weather the long storm of sobriety.

15 Oct 2012

Cognitive Function News and Research

Further Reading

Premenopausal use of hormonal contraceptives may improve women’s cognitive abilities

UC Santa Barbara reports key discovery in interdisciplinary study of split-brain research

Advanced breast cancer that has spread to the brain could be treated with drug combination

Study identifies monoacylglycerol lipase as new therapeutic target to treat Alzheimer's

Additional data from EnVivo’s EVP-6124 Phase 2b trial on AD presented at CTAD meeting

TTP488 slows cognitive decline in patients with mild to moderate Alzheimer's

High-intensity training boosts cognitive function

High-intensity interval training makes middle-aged people smarter

ApoE4 gene becomes less important to quality of life once people hit their 90s

BioLineRx intends to conduct interim analysis of BL-1020 Phase II/III trial for schizophrenia

New data on Posiphen for Alzheimer's disease treatment to be presented at Biotech Symposium

Brain Injury Research Center of Mount Sinai receives fund to research on TBI

Novel insight into impact that Huntington's disease has on the brain

Blood pressure management may slow cognitive decline in PD

High-carb diet may increase risk of mild cognitive impairment among older people

Brain’s biological mechanisms may contribute to diet-related disorders

Adults with HIV can benefit from cognitive training exercises

Mephedrone and memory loss: an interview with Craig Motbey

Cannabis and the endocannabinoid system: an interview with Dr Leonora Long

Smoking cessation programs must be made available for current active-duty war fighters

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News